Cited by 250Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.

Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline

Open access

Peters, Anne L., Ahmann, Andrew J., Battelino, Tadej, Evert, Alison, Hirsch, Irl B., Murad, M. Hassan, Winter, William E., Wolpert, Howard·2016·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2016-2534

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline. EVIDENCE: The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/jc.2016-2534

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Part of this paper’s reference list could not be split into single entries.

1 retracted

RETRACTED: The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study
Grant, P. S., Dorota Dworakowska, B., DeZoysa, N., & Barnes, D. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.06.003 · Cited by 17
Retracted
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Self-citation
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes : dose adjustment for normal eating (DAFNE) randomised controlled trial
Amiel, S. A., Beveridge, S., Bradley, C., Gianfrancesco, C., Heller, S. R., James, P., McKeown, N., Newton, D. F., Newton, L. D., Oliver, L., et al. (2002) · Deakin Research Online (Deakin University) · Cited by 723
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652
Self-citation
Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes
Chamberlain, J. J., Rhinehart, A. S., Shaefer, C. F., & Neuman, A. (2016) · Annals of Internal Medicine · doi:10.7326/m15-3016 · Cited by 644
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 630
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., BALLIRO, C. A., HILLARD, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 617
Insulin Pump Therapy
Weissberg-Benchell, J. A., Antisdel, J. E., & SESHADRI, R. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1079 · Cited by 549
Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Self-citation
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 496
Self-citation
Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic Review and Meta-analysis
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Diabetes self-management education and support in type 2 diabetes: A joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics
Powers, M. A., Bardsley, J., Cypress, M., Duker, P., Funnell, M. M., Hess Fischl, A., Maryniuk, M. D., Siminerio, L., & Vivian, E. (2015) · Diabetes Care · doi:10.2337/dc15-0730 · Cited by 492
The T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality
Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437
Glucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
Misso, M. L., Egberts, K. J., Page, M., O'Connor, D., & Shaw, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005103.pub2 · Cited by 406
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Continuous Subcutaneous Insulin Infusion at 25 Years
Pickup, J. C., & KEEN, H. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.593 · Cited by 397
Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era
Bell, K. J., Smart, C. E., Steil, G. M., Brand-Miller, J. C., King, B., & Wolpert, H. A. (2015) · Diabetes Care · doi:10.2337/dc15-0100 · Cited by 390
Self-citation
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis
Jeitler, K., Horvath, K., Berghold, A., Gratzer, T. W., Neeser, K., Pieber, T. R., & Siebenhofer, A. (2008) · Diabetologia · doi:10.1007/s00125-008-0974-3 · Cited by 375
Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes
Vigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2011) · Diabetes Care · doi:10.2337/dc11-1438 · Cited by 312
A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system.
Swiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302
Self-citation
Implementation of Treatment Protocols in the Diabetes Control and Complications Trial
Diabetes Control and Complications Trial Research Group (1995) · Diabetes Care · doi:10.2337/diacare.18.3.361 · Cited by 285
A Clinical Trial of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Older Adults With Type 2 Diabetes
Herman, W. H., Ilag, L. L., Johnson, S. L., Martin, C. L., Sinding, J., Al Harthi, A., Plunkett, C. D., LaPorte, F. B., Burke, R., Brown, M. B., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1568 · Cited by 265
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial
Hoogma, R. P. L. M., Hammond, P. J., Gomis, R., Kerr, D. E., Bruttomesso, D., Bouter, K. P., Wiefels, K. J., de la Calle, H., Schweitzer, D. H., Pfohl, M., et al. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01738.x · Cited by 253
Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Therapy Are Equally Effective in Type 2 Diabetes
Raskin, P., Bode, B. W., Marks, J. B., Hirsch, I. B., Weinstein, R. L., McGill, J. B., Peterson, G. E., Mudaliar, S. R., & Reinhardt, R. R. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2598 · Cited by 248
Self-citation
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes
Yoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244 · cited 3×
“Yoo et al (103) randomized patients (with T2DM and A1C levels of 8–10% on oral agents or insulin) to RT-CGM use for 3 days per month for 12 weeks vs SBGM six times per week for 12 weeks in the control group.”
Result
Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive
Smart, C. E. M., Evans, M., O’Connell, S. M., McElduff, P., Lopez, P. E., Jones, T. W., Davis, E. A., & King, B. R. (2013) · Diabetes Care · doi:10.2337/dc13-1195 · Cited by 240
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): A randomised open-label controlled trial
Reznik, Y., Cohen, O., Aronson, R., Conget, I., Runzis, S., Castaneda, J., & Lee, S. W. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61037-0 · Cited by 233
Prevention of Hypoglycemia During Exercise in Children With Type 1 Diabetes by Suspending Basal Insulin
the Diabetes Research in Children Network (DirecNet) Study Group (2006) · Diabetes Care · doi:10.2337/dc06-0495 · Cited by 217
Guideline panels should not GRADE good practice statements
Guyatt, G. H., Schünemann, H. J., Djulbegović, B., & Akl, E. A. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.011 · Cited by 212
Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial
O’Connell, M. A., Donath, S. M., O'Neal, D. N., Colman, P. G., Ambler, G. R., Jones, T. W., Davis, E. A., & Cameron, F. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1365-0 · Cited by 212
Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study
Lachin, J. M., Orchard, T. J., Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2116 · Cited by 206
Dietary Fat Acutely Increases Glucose Concentrations and Insulin Requirements in Patients With Type 1 Diabetes
Wolpert, H. A., Atakov-Castillo, A., Smith, S. A., & Steil, G. M. (2012) · Diabetes Care · doi:10.2337/dc12-0092 · Cited by 199
Self-citation
The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199 · cited 1×
“Evidence This recommendation is based on data from one wellperformed large-scale RCT performed by Vigersky and colleagues (101, 102) and one other smaller study (103) showing similar outcomes.”
Result
Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII
Hirsch, I. B., Bode, B. W., Garg, S., Lane, W. S., Sussman, A., Hu, P., Santiago, O. M., Kolaczynski, J. W., & for the Insulin Aspart CSII/MDI Comparison Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.3.533 · Cited by 197
Self-citation
Frequent Hypoglycemia Among Elderly Patients With Poor Glycemic Control
Munshi, M. N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.539 · Cited by 196
A Randomized Trial of Continuous Subcutaneous Insulin Infusion and Intensive Injection Therapy in Type 1 Diabetes for Patients With Long-Standing Poor Glycemic Control
DeVries, J. H., Snoek, F. J., Kostense, P. J., Masurel, N., Heine, R. J., & On behalf of the Dutch Insulin Pump Study Group (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2074 · Cited by 185
Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial
Allen, N. A., Fain, J. A., Braun, B., & Chipkin, S. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.006 · Cited by 182 · cited 1×
“blinded (instead of real-time) CGM use (106).”
Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task Force
Grunberger, G., Abelseth, J. M., Bailey, T. S., Bode, B. W., Handelsman, Y., Hellman, R., Jovanovič, L., Lane, W. S., Raskin, P., Tamborlane, W. V., et al. (2014) · Endocrine Practice · doi:10.4158/ep14145.ps · Cited by 181
Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
Hanaire, H. P., Melki, V., Bessières-Lacombe, S., & Tauber, J.-P. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1232 · Cited by 172
Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years
Linkeschova, R., Raoul, M., Bott, U., Berger, M., & Spraul, M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00713.x · Cited by 165
Bolus Calculator: A Review of Four “Smart” Insulin Pumps
Zisser, H., Robinson, L., Bevier, W. C., Dassau, E., Ellingsen, C., Doyle, F. J., & Jovanovic, L. G. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0284 · Cited by 164
A Bolus Calculator Is an Effective Means of Controlling Postprandial Glycemia in Patients on Insulin Pump Therapy
Gross, T. M., Kayne, D. M., King, A. B., Rother, C., & Juth, S. E. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503765691848 · Cited by 144
Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs
Heinemann, L., Fleming, G. A., Petrie, J. R., Holl, R. W., Bergenstal, R. M., & Peters, A. L. (2015) · Diabetes Care · doi:10.2337/dc15-0168 · Cited by 143
Self-citation
Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients
Wainstein, J., Metzger, M., Boaz, M., Minuchin, O., Cohen, Y., Yaffe, A. E., Yerushalmy, Y., Raz, I., & Harman‐Boehm, I. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01597.x · Cited by 136
Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes
Barnard, K. D., Lloyd, C. E., & Skinner, T. C. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02120.x · Cited by 136
Efficacy of Continuous Glucose Monitoring in Improving Glycemic Control and Reducing Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Trials
Gandhi, G. Y., Kovalaske, M. A., Kudva, Y. C., Walsh, K., Elamin, M. B., Beers, M. C., Coyle, C., Goalen, M. J., Murad, M. S., Erwin, P. J., et al. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500419 · Cited by 136
Self-citation
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine
Bruttomesso, D., Crazzolara, D., Maran, A., Costa, S., Pos, M. D., Girelli, A., Lepore, G., Aragona, M., Iori, E., Valentini, U., et al. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02365.x · Cited by 136
Intensive Insulin Therapy With Insulin Lispro
Tsui, E. Y. L., Barnie, A., Ross, S., Parkes, R. K., & Zinman, B. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1722 · Cited by 131
Continuous Glucose Monitoring in Children with Type 1 Diabetes
⁎ (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.03.047 · Cited by 128
Sustained Benefit of Continuous Glucose Monitoring on A1C, Glucose Profiles, and Hypoglycemia in Adults With Type 1 Diabetes
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0846 · Cited by 121
Self-Monitoring of Blood Glucose (SMBG) in Insulin- and Non–Insulin-Using Adults with Diabetes: Consensus Recommendations for Improving SMBG Accuracy, Utilization, and Research
Hirsch, I. B., Bode, B. W., Childs, B. P., Close, K. L., Fisher, W. A., Gavin, J. R., Ginsberg, B. H., Raine, C. H., & Verderese, C. A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0104 · Cited by 121
Self-citation
Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes
Bolli, G. B., Kerr, D., Thomas, R., Torlone, E., Sola-Gazagnes, A., Vitacolonna, E., Selam, J. L., & Home, P. D. (2009) · Diabetes Care · doi:10.2337/dc08-1874 · Cited by 119
Post‐prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes
Chase, H. P., Saib, S. Z., MacKenzie, T., Hansen, M. M., & Garg, S. K. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00685.x · Cited by 116
Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability
Pickup, J. C., Kidd, J., Burmiston, S., & Yemane, N. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.614 · Cited by 110
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis
Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0132-5 · Cited by 110
Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes
Pickup, J. C., & Renard, É. (2008) · Diabetes Care · doi:10.2337/dc08-s235 · Cited by 107
Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control
Ziegler, R., Cavan, D. A., CRANSTON, I. C., Barnard, K. D., Ryder, J., Vogel, C., Parkin, C. G., Koehler, W., Vesper, I., Petersen, B., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0251 · Cited by 106
Exercise With and Without an Insulin Pump Among Children and Adolescents With Type 1 Diabetes Mellitus
Admon, G., Weinstein, Y., Falk, B., Weintrob, N., Benzaquen, H., Ofan, R., Fayman, G., Zigel, L., Constantini, N., & Phillip, M. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2428 · Cited by 104
Effectiveness of Intensive Insulin Therapy by Multiple Daily Injections and Continuous Subcutaneous Infusion: A Comparison Study in Type 2 Diabetes with Conventional Insulin Regimen Failure
Berthe, E., Lireux, B., Coffin, C., Goulet-Salmon, B., Houlbert, D., Boutreux, S., Fradin, S., & Reznik, Y. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-970423 · Cited by 103
Clinical use of U-500 regular insulin: Review and meta-analysis
Reutrakul, S., Wroblewski, K., & Brown, R. L. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600229 · Cited by 94
Optimal Insulin Pump Dosing and Postprandial Glycemia Following a Pizza Meal Using the Continuous Glucose Monitoring System
Jones, S. M., Quarry-Horn, J. L., Caldwell-McMillan, M., Mauger, D. T., & Gabbay, R. A. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.233 · Cited by 92
Insulin Pump Therapy Is Associated with Less Post-Exercise Hyperglycemia than Multiple Daily Injections: An Observational Study of Physically Active Type 1 Diabetes Patients
Yardley, J. E., Iscoe, K. E., Sigal, R. J., Kenny, G. P., Perkins, B. A., & Riddell, M. C. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0168 · Cited by 90
Transitioning Insulin Pump Therapy from the Outpatient to the Inpatient Setting: A Review of 6 Years' Experience with 253 Cases
Cook, C. B., Beer, K. A., Seifert, K. M., Boyle, M. E., Mackey, P., & Castro, J. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600502 · Cited by 80
Statement by the American Association of Clinical Endocrinologists Consensus Panel on Insulin Pump Management
Grunberger, G., Bailey, T. S., Cohen, A. J., Flood, T. M., Handelsman, Y., Hellman, R., Jovanovič, L., Moghissi, E. S., Orzeck, E. A., & AACE Insulin Pump Management Task Force (2010) · Endocrine Practice · doi:10.4158/ep.16.5.746 · Cited by 66
Insulin Pump Therapy Guidelines for Successful Outcomes
Scheiner, G., Sobel, R., Smith, D., Pick, A. J., Kruger, D. F., King, J., & Green, K. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709333493 · Cited by 65
Continuous glucose monitoring pilot in low-income type 1 diabetes patients
Sequeira, P. A., Montoya, L., Ruelas, V., Xing, D., Chen, V., Beck, R., & Peters, A. L. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0072 · Cited by 59
The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
Lee, S. W., Cao, M., Sajid, S., Hayes, M., Choi, L., Rother, C., & de León, R. (2004) · PubMed · Cited by 59
Insulin Pump Therapy in Patients with Type 2 Diabetes Safely Improved Glycemic Control Using a Simple Insulin Dosing Regimen
Edelman, S. V., Bode, B. W., Bailey, T. S., Kipnes, M. S., Brunelle, R. L., Chen, X., & Frías, J. P. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0034 · Cited by 58
Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay®) on glycaemic control in type 1 and type 2 diabetes patients
Cosson, E., Hamo-Tchatchouang, E., Dufaitre-Patouraux, L., Attali, J.-R., Pariès, J., & Schaepelynck-Bélicar, P. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.02.006 · Cited by 57
Clinical Usefulness of a Bolus Calculator in Maintaining Normoglycaemia in Active Professional Patients with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion
Klupa, T., Benbenek‐Klupa, T., Malecki, M. T., Szalecki, M., & Sieradzki, J. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600531 · Cited by 55
Guidelines for Application of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Perioperative Period
Boyle, M. E., Seifert, K. M., Beer, K. A., Apsey, H. A., Nassar, A. A., Littman, S. D., Magallanez, J. M., Schlinkert, R. T., Stearns, J. D., Hovan, M. J., et al. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600123 · Cited by 54
The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis
Sharma, D., Morrison, G., Joseph, F., Purewal, T. S., & Weston, P. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2282-6 · Cited by 53
Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: A Meta-analysis
Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0028-1119405 · Cited by 48
Use of U-500 Regular Insulin by Continuous Subcutaneous Insulin Infusion in Patients with Type 2 Diabetes and Severe Insulin Resistance
Lane, W. S. (2006) · Endocrine Practice · doi:10.4158/ep.12.3.251 · Cited by 48
How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients’ self‐management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) course
Rankin, D., Cooke, D. D., Clark, M., Heller, S. R., Elliott, D., Lawton, J., & for the UK NIHR DAFNE Study Group (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03243.x · Cited by 45
Insulin Pump Therapy is Equally Effective and Safe in Elderly and Young Type 1 Diabetes Patients
Matejko, B., Cyganek, K., Katra, B., Galicka-Latała, D., Grzanka, M., Malecki, M. T., & Klupa, T. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.254 · Cited by 43
In-Hospital Management of Adults Using Insulin Pump Therapy
Houlden, R. L., & Moore, S. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.01.011 · Cited by 41
Clinical Efficacy and Patient Satisfaction with U-500 Insulin Pump Therapy in Patients with Type 2 Diabetes
Bulchandani, D. G., Konrady, T., & Hamburg, M. S. (2007) · Endocrine Practice · doi:10.4158/ep.13.7.721 · Cited by 41
A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone
Thomas, R. M., Aldibbiat, A. M., Griffin, W., Cox, M. A. A., Leech, N., & Shaw, J. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02196.x · Cited by 40
Associations Between Improved Glucose Control and Patient-Reported Outcomes After Initiation of Insulin Pump Therapy in Patients with Type 2 Diabetes Mellitus
Peyrot, M. F., Rubin, R. R., Chen, X., & Frías, J. P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0167 · Cited by 40
Long-Term Efficacy of Insulin Pump Therapy on Glycemic Control in Adults with Type 1 Diabetes Mellitus
Orr, C. J., Hopman, W. M., Yen, J. L., & Houlden, R. L. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0131 · Cited by 39
Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes
Lepore, G., Dodesini, A. R., Nosari, I., Scaranna, C., Corsi, A., & Trevisan, R. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.04.001 · Cited by 34
Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus
Crasto, W., Jarvis, J., Hackett, E., Nayyar, V., McNally, P. G., Davies, M. J., & Lawrence, I. G. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.073379 · Cited by 34
Identifying risk and preventing progression to Type 2 diabetes in vulnerable and disadvantaged adults: a pragmatic review
Taylor, J., Cottrell, C., Chatterton, H. T., Hill, J., Hughes, R., Wohlgemuth, C. M., & Holt, R. I. G. (2012) · Diabetic Medicine · doi:10.1111/dme.12027 · Cited by 33
Variations in the quality and sustainability of long‐term glycaemic control with continuous subcutaneous insulin infusion
Nixon, R., Folwell, R., & Pickup, J. C. (2014) · Diabetic Medicine · doi:10.1111/dme.12486 · Cited by 32
The Current Status of Bolus Calculator Decision-Support Software
Klonof, D. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600501 · Cited by 32
Practical Aspects of Real-Time Continuous Glucose Monitoring
Gilliam, L. K., & Hirsch, I. B. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0135 · Cited by 31
Self-citation
Approach to the adult hospitalized patient on an insulin pump
Lansang, M. C., Modic, M. B., Sauvey, R., Lock, P., Ross, D., Combs, P., & Kennedy, L. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2109 · Cited by 30
The Impact of Baseline Hemoglobin A1c Levels Prior to Initiation of Pump Therapy on Long-Term Metabolic Control
Pinhas‐Hamiel, O., Tzadok, M., Hirsh, G., Boyko, V., Graph‐Barel, C., Lerner‐Geva, L., & Reichman, B. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0006 · Cited by 28
Insulin Pump Therapy in Patients with Type 1 Diabetes Mellitus: Results of the Nationwide Quality Circle in Germany (ASD) 1999 - 2000
Hunger-Dathe, W., Braun, A., Müller, U., Schiel, R., Femerling, M., & Risse, A. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-44290 · Cited by 28
Predicting the Effectiveness of Insulin Pump Therapy on Glycemic Control in Clinical Practice: A Retrospective Study of Patients with Type 1 Diabetes from 10 Outpatient Diabetes Clinics in Sweden over 5 Years
Clements, M. A., Matuleviciene, V., Attvall, S., Ekelund, M., Pivodic, A., Dahlqvist, S., Fahlén, M., Haraldsson, B. S., & Lind, M. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0139 · Cited by 27
The Effect of Long-Term Use of U-500 Insulin Via Continuous Subcutaneous Infusion on Durability of Glycemic Control and Weight in Obese, Insulin-Resistant Patients with Type 2 Diabetes
Lane, W. S., Weinrib, S. L., Rappaport, J. M., Hale, C. B., Farmer, L. K., & Lane, R. S. (2012) · Endocrine Practice · doi:10.4158/ep12226.or · Cited by 27
Insulin Pump Therapy in the Perioperative Period: A Review of Care after Implementation of Institutional Guidelines
Boyle, M. E., Seifert, K. M., Beer, K. A., Mackey, P., Schlinkert, R. T., Stearns, J. D., & Cook, C. B. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600504 · Cited by 25
The use of U‐500 regular insulin in the management of patients with obesity and insulin resistance
Jones, P., & IDRIS, I. R. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12094 · Cited by 24
ProAct Study: New Features of Insulin Pumps Improve Diabetes Management and Glycemic Control in Patients after Transition of Continuous Subcutaneous Insulin Infusion Systems
Ziegler, R., Tubili, C., Chico, A. I., Guerci, B., Lundberg, E., Borchert, M., Löffler, A., Bloethner, S., Weißmann, J., & Pfützner, A. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0090 · Cited by 24
Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy
Matejko, B., SKUPIEN, J. K., Mrozińska, S., Grzanka, M., Cyganek, K., Kieć‐Wilk, B., Malecki, M. T., & Klupa, T. (2014) · Endocrine · doi:10.1007/s12020-014-0274-2 · Cited by 23
Effect of educational components and strategies associated with insulin pump therapy: a systematic review
Jayasekara, R. S., Munn, Z., & Lockwood, C. S. (2011) · International Journal of Evidence-Based Healthcare · doi:10.1111/j.1744-1609.2011.00228.x · Cited by 18
Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446]
Cavan, D. A., Ziegler, R., CRANSTON, I. C., Barnard, K. D., Ryder, J., Vogel, C., Parkin, C. G., Koehler, W., Vesper, I., Petersen, B., et al. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-102 · Cited by 16
Continuous Subcutaneous Insulin Infusion (CSII) in Inpatient Setting: Unmet Needs and the Proposal of a CSII Unit
Morviducci, L., Flaviani, A. D., Lauria, A., Pitocco, D., Pozzilli, P., SURACI, C., & Frontoni, S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0056 · Cited by 13
An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus
Papargyri, P., Rodríguez, S. O., Hernández, J. J. C., Álvarez, M., Recio‐Córdova, J. M., Gómez, M. D., Marcos, A. I. S., López, R. A. I., Ruiz, A. H., Oriol, M. B., et al. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.05.003 · Cited by 10
Continuous Glucose Monitoring Technology for Personal Use
Evert, A. B., Trence, D., Catton, S., & Huynh, P. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709335467 · Cited by 9
Self-citation
Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes
Quirós, C., Patrascioiu, I., Giménez, M., Vinagre, I., Vidal, M., Jansà, M., & Conget, I. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.06.003 · Cited by 7
45 carb-counting tips.
Neithercott, T. (2014) · PubMed · Cited by 3
The basics of insulin pumps.
Neithercott, T. (2014) · PubMed · Cited by 2
Exercising with an insulin pump.
Colberg, S. R. (2005) · PubMed · Cited by 1

Research works printed but not linked: 2

American Diabetes Association. 7. Approaches to glycemic treat- ment. Diabetes Care. 2015;38:S41-S48.
Golden SH, Brown T, Yeh HC, et al. AHRQ Comparative Effec- tiveness Reviews. Methods for Insulin Delivery and Glucose Mon- itoring: Comparative Effectiveness Review No. 57. Rockville, MD: Agency for Healthcare Research and Quality; 2012.

Sorted by citations

Type 1 diabetes
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Self-citation
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684
Continuous glucose monitoring sensors for diabetes management: A review of technologies and applications
Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458

See all 250

Authors: Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H.
Affiliations: University of Southern California (US)
ORCID: Peters, Anne L.
Ahmann, Andrew J.
Battelino, Tadej
Evert, Alison
Hirsch, Irl B.
Murad, M. Hassan
Winter, William E.
Wolpert, Howard
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2016-11
Volume: 101
Issue: 11
Pages: 3922-3937
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2016-2534
OpenAlex: W2518284272
Cited by: 250
References: 115
Citations by year: 2026: 13 · 2025: 24 · 2024: 17 · 2023: 19 · 2022: 23 · 2021: 39 · 2020: 31 · 2019: 32 · 2018: 31 · 2017: 19 · 2016: 2
FWCI: 28.12
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords: diabetes technology, insulin pump therapy, continuous glucose monitoring, adults with diabetes, diabetes management, clinical guidelines
MeSH terms: Adult, Blood Glucose, Combined Modality Therapy, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diet, Diabetic, Endocrinology, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, International Agencies, Patient Education as Topic, Societies, Scientific, Exercise, Drug Monitoring, Monitoring, Ambulatory, Evidence-Based Medicine, Consensus, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks